4.7 Article

Quality Indicators for Gastric Cancer Surgery: A Survey of Practicing Pathologists in Ontario

Journal

ANNALS OF SURGICAL ONCOLOGY
Volume 16, Issue 7, Pages 1883-1889

Publisher

SPRINGER
DOI: 10.1245/s10434-009-0468-7

Keywords

-

Funding

  1. Ministry of Health and Long Term Care Career Scientist Award

Ask authors/readers for more resources

Adequate lymph node (LN) assessment and R0 resection are critical to the staging and management of gastric cancer. The American Joint Committee on Cancer/International Union Against Cancer recommend at least 15 LN be assessed, and the literature suggests a gross disease-free margin of 5-6 cm be achieved. Results of an Ontario general surgeons' survey indicated these standards were not widely known. Because disease management is highly collaborative, we surveyed pathologists to assess their knowledge of LN assessment and margins for processing gastric cancer specimens. Pathologists were identified by the College of Physicians and Surgeons of Ontario and MD Select databases. Participants were surveyed online or by mail. Pathologists indicated a goal of assessing < 5 LN (2%), 5-10 LN (27%), 10-15 LN (40%), 15-20 LN (20%), or > 20 LN (11%). Most self-reported an actual assessment of 5-10 LN (49%), with 88% reporting a number below current standards. Additionally, 54% of responding pathologists identified > 1 cm as an adequate gross margin, and 89% of pathologists indicated a response below current standards. Ninety-four percent of pathologists agreed that more education on gastric cancer is valuable. To improve the quality of gastric cancer management, our findings suggest the need for clear, consistent guidelines for adequate gross margin resection length. Furthermore, there is a critical need for education aimed at closing the knowledge gap among practicing pathologists and surgeons regarding current recommended guidelines for LN assessment and adequate margin length.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study

Soyoun Rachel Kim, Alicia Tone, Raymond H. Kim, Matthew Cesari, Blaise A. Clarke, Lua Eiriksson, Tae Hart, Melyssa Aronson, Spring Holter, Alice Lytwyn, Katherine Lajkosz, Leslie Oldfield, Steven Gallinger, Marcus Q. Bernardini, Amit M. Oza, Bojana Djordjevic, Jordan Lerner-Ellis, Emily Van de Laar, Danielle Vicus, Trevor Pugh, Aaron Pollett, Sarah E. Ferguson

Summary: The study compared the clinical characteristics, survival, and recurrence patterns between MMRd and MMRi EEC. The results showed that MMRd tumors have more aggressive features, lower recurrence-free survival, and are more likely to recur in retroperitoneal lymph nodes. MLH1 methylated tumors had the worst prognostic features and survival outcomes.

GYNECOLOGIC ONCOLOGY (2021)

Article Pathology

An Integrative DNA Sequencing and Methylation Panel to Assess Mismatch Repair Deficiency

Leslie E. Oldfield, Tiantian Li, Alicia Tone, Melyssa Aronson, Melissa Edwards, Spring Holter, Rene Quevedo, Emily Van de laar, Jordan Lerner-Ellis, Aaron Pollett, Blaise Clarke, Uri Tabori, Steven Gallinger, Sarah E. Ferguson, Trevor J. Pugh

Summary: The study developed an integrated targeted sequencing protocol called MultiMMR, which can test for promoter methylation, mutations, copy number alterations, copy neutral loss of heterozygosity, and microsatellite instability from a single aliquot of DNA. The study showed that MultiMMR can recapitulate clinical testing results, explain MMR loss in incomplete or inconclusive testing, and identify known variants. Promoter methylation and microsatellite instability analysis were highly concordant with clinical testing results.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

Article Oncology

Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer

Soyoun Rachel Kim, Alicia Tone, Raymond H. Kim, Matthew Cesari, Blaise A. Clarke, Lua Eiriksson, Tae L. Hart, Melyssa Aronson, Spring Holter, Alice Lytwyn, Manjula Maganti, Leslie Oldfield, Steven Gallinger, Marcus Q. Bernardini, Amit M. Oza, Bojana Djordjevic, Jordan Lerner-Ellis, Emily van de Laar, Danielle Vicus, Trevor J. Pugh, Aaron Pollett, Sarah E. Ferguson

Summary: The implementation of a navigated genetic program resulted in a high rate of genetic assessment in patients with endometrial or nonserous/nonmucinous ovarian cancer at risk for Lynch syndrome.

CANCER (2021)

Meeting Abstract Oncology

Performance characteristics of brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed ovarian cancers.

Rachel Soyoun Kim, Alicia Tone, Raymond Kim, Matthew Cesari, Blaise Clarke, Lua Ruhiyyih Eiriksson, Hart Tae, Alice Lytwyn, Manjula Maganti, Steven Gallinger, Marcus Bernardini, Amit M. Oza, Bojana Djordjevic, Jordan Lerner-Ellis, Emily Van de laar, Danielle Vicus, Trevor J. Pugh, Aaron Pollett, Sarah E. Ferguson

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers

Soyoun Rachel Kim, Alicia Tone, Raymond Kim, Matthew Cesari, Blaise Clarke, Tae Hart, Melyssa Aronson, Spring Holter, Alice Lytwyn, Manjula Maganti, Leslie Oldfield, Steven Gallinger, Marcus Q. Bernardini, Amit M. Oza, Bojana Djordjevic, Jordan Lerner-Ellis, Emily Van de Laar, Danielle Vicus, Trevor J. Pugh, Aaron Pollett, Sarah Elizabeth Ferguson, Lua Eiriksson

Summary: The study found that the brief Family History Questionnaire can be used to identify women with ovarian cancer at risk of Lynch syndrome. Compared to the extended Family History Questionnaire, the brief Family History Questionnaire had higher sensitivity. A combined approach with both the brief Family History Questionnaire and immunohistochemistry correctly identified all patients with Lynch syndrome.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Article Oncology

Game Changer: Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management

Salma Shickh, Leslie E. Oldfield, Marc Clausen, Chloe Mighton, Agnes Sebastian, Alessia Calvo, Nancy N. Baxter, Lesa Dawson, Lynette S. Penney, William Foulkes, Mark Basik, Sophie Sun, Kasmintan A. Schrader, Dean A. Regier, Aly Karsan, Aaron Pollett, Trevor J. Pugh, Raymond H. Kim, Yvonne Bombard

Summary: This study explores the views of health professionals on the utility of circulating tumor DNA (ctDNA) testing in the management of hereditary cancer syndromes (HCS). The study finds that professionals have varying opinions on the use of ctDNA testing, with some optimistic about its potential to transform early cancer detection, while others are hesitant due to concerns about invasiveness and limited utility.

ONCOLOGIST (2022)

Article Genetics & Heredity

Development of a comprehensive approach to adult hereditary cancer testing in Ontario

Kathleen Anne Bell, Raymond Kim, Melyssa Aronson, Brittany Gillies, Arif Ali Awan, Kathy Chun, Jennifer Hart, Rachel Healey, Linda Kim, Goran Klaric, Karen Panabaker, Peter J. B. Sabatini, Bekim Sadikovic, Shamini Selvarajah, Amanda C. Smith, Tracy L. Stockley, Andrea K. Vaags, Andrea Eisen, Aaron Pollett, Harriet Feilotter

Summary: Ontario has achieved standardization and coordination of cancer genetic testing across the province through the development of a standardized cancer gene list and eligibility criteria for hereditary cancer testing.

JOURNAL OF MEDICAL GENETICS (2023)

Article Oncology

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023

Essa Al-Mansor, Meghan Mahoney, Maxime Chenard-Poirier, Ravi Ramjeesingh, Vimoj Nair, Erin Kennedy, Gordon Locke, Stephen Welch, Scott Berry, Felix Couture, Elena Elimova, Aaron Pollett, Aamer Mahmud, Brooke Wilson, Dawn Armstrong, Conrad Falkson, Timothy Asmis, Michael Vickers, Rachel Goodwin

Summary: The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023 aimed to develop consensus statements on emerging and evolving treatment paradigms. Participants included medical oncologists and surgical oncologists from Canada, who reviewed reports and literature to reach consensus opinions.

CURRENT ONCOLOGY (2023)

Meeting Abstract Oncology

MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCERS USING AN INTEGRATIVE DNA SEQUENCING PANEL

Soyoun Rachel Kim, Leslie Oldfield, Espin-Garcia Osvaldo, Kathy Han, Danielle Vicus, Lua Eiriksson, Alicia Tone, Aaron Pollett, Emily Van De laar, Stephanie Pederson, Johanna Wellum, Blaise Clarke, Marcus Bernardini, Sarah Ferguson

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Meeting Abstract Oncology

ARE MISMATCH REPAIR DEFICIENT ENDOMETRIAL CANCER RECURRENCES MORE SALVAGEABLE THAN INTACT COHORT?

Soyoun Rachel Kim, Ilias Ettayebi, Gabrielle Trepanier, Lucy Zhao, Emily Van De laar, Espin-Garcia Osvaldo, Aaron Pollett, Lua Eiriksson, Kathy Han, Sarah Ferguson

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Meeting Abstract Oncology

Are mismatch repair deficient endometrial cancer recurrences more salvageable than intact cohort?

Soyoun Rachel Kim, Ilias Ettayebi, Gabrielle Trepanier, Lucy Zhao, Emily Van de Laar, Osvaldo Espin-Garcia, Aaron Pollett, Lua Eiriksson, Kathy Han, Sarah Ferguson

GYNECOLOGIC ONCOLOGY (2022)

Meeting Abstract Oncology

Molecular classification of endometrial cancers using an integrative DNA sequencing panel

Soyoun Rachel Kim, Leslie Oldfield, Osvaldo Espin-Garcia, Kathy Han, Danielle Vicus, Lua Eiriksson, Alicia Tone, Aaron Pollett, Emily Van de Laar, Stephanie Pedersen, Johanna Wellum, Marcus Bernardini, Trevor Pugh, Sarah Ferguson

GYNECOLOGIC ONCOLOGY (2022)

Meeting Abstract Medicine, Research & Experimental

MMR GINIE: A Novel Excel-based Natural Language Processing Tool Identifies Mismatch Repair Gene Status from Pathology Reports

Boris Virine, Aaron Pollett

LABORATORY INVESTIGATION (2022)

Meeting Abstract Oncology

Performance characteristics of brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed ovarian cancers

Rachel Soyoun Kim, Alicia Tone, Matthew Cesari, Lua Eiriksson, Tae Hart, Melyssa Aronson, Spring Holter, Alice Lytwyn, Manjula Maganti, Leslie Oldfield, Marcus Bernardini, Amit Oza, Bojana Djordjevic, Jordan Lerner-Ellis, Emily Van de Laar, Danielle Vicus, Trevor Pugh, Aaron Pollett, Sarah Ferguson

GYNECOLOGIC ONCOLOGY (2021)

No Data Available